Portal de Periódicos da CAPES

Recommendations for Prevention of and Therapy for Exposure to B Virus ( Cercopithecine Herpesvirus 1)

2002; Oxford University Press; Volume: 35; Issue: 10 Linguagem: Inglês

10.1086/344754

1537-6591

Jeffrey I. Cohen, D. S. Davenport, John A. Stewart, Scott Deitchman, Julia K. Hilliard, Louisa E. Chapman,

Parvovirus B19 Infection Studies

B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis.